Skip to content

Public FDA record

Z-0281-2014: Ray Station Radiation Therapy Treatment Planning System, Model Numbers 3.0, 3.5 and 4.0

Recall record Z-0281-2014 for RAYSEARCH LABORATORIES AB. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0281-2014
Company in FDA record
RAYSEARCH LABORATORIES AB
FDA classification date
Nov 14, 2013
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Ray Search Laboratories found an issue with the dose calculation for Elekta motorized wedges in Ray Station 3.0, 3.5 and 4.0. The error presents when a wedge is used for a beam and the wedge angle differs from 60 degrees.

Source facts

Action
Medical Device Correction Letters dated 10/23/13 were e-mailed to the user accounts on 10/23/13.
Initiated
2013-10-23
Root cause
Software design
Terminated
2017-02-17
Distribution
US Distribution in the states of: California, Colorado, Delaware, Florida, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, Tennessee, and Virginia.
Recall number
Z-0281-2014
Recall status
Terminated
CDRH record ID
122696
FDA classified
2013-11-14
Recall event number
66600

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗